NOS2 and breast carcinoma: In breast cancer, the inhibition of NOS2 with L-NMMA enhanced docetaxel-induced apoptosis in triple-negative breast cancer (TNBC) cellular and mouse models, which may indicate that high levels of NO contribute in these models to chemoresistance through endoplasmic reticulum (ER) stress-related pathways [17].